| 2026-06-11 | Trial | New trial registered: CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial | Trial register ClinicalTrials.gov |
| 2026-06-05 | Trial | New trial registered: A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males | Trial register ClinicalTrials.gov |
| 2026-04-14 | Trial | New trial registered: Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-03-04 | Results | Results posted: The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants. | Trial register ClinicalTrials.gov |
| 2026-02-23 | Trial | New trial registered: Comparing the Safety and Efficacy of Insulin GLARGINE and DEGLUDEC in Glucocorticoid Induced HYPERGLYCEMIA in Hospitalized Patients". | Trial register ClinicalTrials.gov |
| 2026-02-04 | Trial | New trial registered: Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-01-14 | Trial | New trial registered: Single-ascending Dose Study of HEC-151 Injection | Trial register ClinicalTrials.gov |
| 2025-11-21 | Trial | New trial registered: Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State | Trial register ClinicalTrials.gov |
| 2025-10-14 | Label | FDA label revised: Xultophy 100/3.6 (BLA208583) | Regulator FDA drug label register |
| 2025-10-09 | Trial | New trial registered: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin | Trial register ClinicalTrials.gov |
| 2025-09-15 | Trial | New trial registered: Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2025-08-28 | Trial | New trial registered: Comparison Study of Insulin GZR4 With Insulin Degludec | Trial register ClinicalTrials.gov |
| 2025-08-26 | Results | Results posted: A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not U | Trial register ClinicalTrials.gov |
| 2025-06-24 | Results | Results posted: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection The | Trial register ClinicalTrials.gov |
| 2025-06-24 | Trial | New trial registered: A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2025-06-12 | Results | Results posted: A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insu | Trial register ClinicalTrials.gov |
| 2025-06-12 | Trial | New trial registered: A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs | Trial register ClinicalTrials.gov |
| 2025-06-03 | Results | Results posted: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin | Trial register ClinicalTrials.gov |
| 2025-05-16 | Results | Results posted: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time | Trial register ClinicalTrials.gov |
| 2025-04-18 | Trial | New trial registered: A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2025-04-13 | Trial | New trial registered: A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2025-02-20 | Results | Results posted: A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Ty | Trial register ClinicalTrials.gov |
| 2025-01-10 | Trial | New trial registered: A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin | Trial register ClinicalTrials.gov |
| 2024-12-04 | Results | Results posted: A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-11-12 | Trial | New trial registered: A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2024-10-30 | Results | Results posted: iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) | Trial register ClinicalTrials.gov |
| 2024-10-18 | Results | Results posted: Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2024-09-05 | Results | Results posted: Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment | Trial register ClinicalTrials.gov |
| 2024-08-19 | Trial | New trial registered: A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-08-16 | Trial | New trial registered: A Clinical Study of GZR33 and GZR101 in Healthy Subjects | Trial register ClinicalTrials.gov |
| 2024-08-14 | Trial | New trial registered: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-07-29 | Results | Results posted: Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D | Trial register ClinicalTrials.gov |
| 2024-06-10 | Trial | New trial registered: A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects | Trial register ClinicalTrials.gov |
| 2024-06-03 | Label | FDA label revised: Insulin Degludec (BLA203314) | Regulator FDA drug label register |
| 2024-05-31 | Label | FDA label revised: Insulin Degludec (BLA203314) | Regulator FDA drug label register |
| 2024-05-10 | Trial | New trial registered: The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2024-03-20 | Results | Results posted: Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes | Trial register ClinicalTrials.gov |
| 2024-03-01 | Trial | New trial registered: A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting | Trial register ClinicalTrials.gov |
| 2024-02-28 | Results | Results posted: Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose | Trial register ClinicalTrials.gov |
| 2024-02-28 | Trial | New trial registered: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) | Trial register ClinicalTrials.gov |
| 2024-02-22 | Label | FDA label revised: TRESIBA (BLA203314) | Regulator FDA drug label register |
| 2024-02-02 | Trial | New trial registered: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec | Trial register ClinicalTrials.gov |
| 2024-01-11 | Trial | New trial registered: A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2023-12-28 | Trial | New trial registered: A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM | Trial register ClinicalTrials.gov |
| 2023-12-21 | Trial | New trial registered: Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia | Trial register ClinicalTrials.gov |
| 2023-12-12 | Label | FDA label revised: Tresiba (BLA203314) | Regulator FDA drug label register |
| 2023-12-01 | Trial | New trial registered: A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level | Trial register ClinicalTrials.gov |
| 2023-11-15 | Trial | New trial registered: A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2023-10-26 | Trial | New trial registered: The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants. | Trial register ClinicalTrials.gov |
| 2023-09-28 | Trial | New trial registered: Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus | Trial register ClinicalTrials.gov |
| 2023-09-13 | Trial | New trial registered: Degludec Insulin Use in Critically Ill Patients | Trial register ClinicalTrials.gov |
| 2023-09-08 | Results | Results posted: IDegLira HIGH Trial | Trial register ClinicalTrials.gov |
| 2023-06-15 | Trial | New trial registered: INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2023-04-07 | Trial | New trial registered: A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Dia | Trial register ClinicalTrials.gov |
| 2023-03-14 | Trial | New trial registered: Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP- | Trial register ClinicalTrials.gov |
| 2023-02-08 | Results | Results posted: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-12-07 | Trial | New trial registered: Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes | Trial register ClinicalTrials.gov |
| 2022-11-14 | Results | Results posted: Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients | Trial register ClinicalTrials.gov |
| 2022-11-02 | Results | Results posted: A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Trial register ClinicalTrials.gov |
| 2022-10-27 | Results | Results posted: A Study of LY3209590 in Participants With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-10-12 | Trial | New trial registered: A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Inj | Trial register ClinicalTrials.gov |
| 2022-09-23 | Trial | New trial registered: Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment | Trial register ClinicalTrials.gov |
| 2022-09-15 | Trial | New trial registered: Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy | Trial register ClinicalTrials.gov |
| 2022-07-29 | Trial | New trial registered: A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With | Trial register ClinicalTrials.gov |
| 2022-07-21 | Results | Results posted: Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-07-19 | Trial | New trial registered: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injecti | Trial register ClinicalTrials.gov |
| 2022-07-01 | Label | FDA label revised: Tresiba (BLA203314) | Regulator FDA drug label register |
| 2022-07-01 | Label | FDA label revised: Insulin Degludec (BLA203314) | Regulator FDA drug label register |
| 2022-06-28 | Trial | New trial registered: Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec | Trial register ClinicalTrials.gov |
| 2022-06-17 | Trial | New trial registered: cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances | Trial register ClinicalTrials.gov |
| 2022-06-14 | Trial | New trial registered: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM | Trial register ClinicalTrials.gov |
| 2022-06-10 | Trial | New trial registered: iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) | Trial register ClinicalTrials.gov |
| 2022-06-03 | Results | Results posted: A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-06-02 | Results | Results posted: Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. | Trial register ClinicalTrials.gov |
| 2022-05-05 | Trial | New trial registered: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time | Trial register ClinicalTrials.gov |
| 2022-05-04 | Trial | New trial registered: Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients | Trial register ClinicalTrials.gov |
| 2022-04-27 | Results | Results posted: Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-03-31 | Results | Results posted: Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-03-11 | Trial | New trial registered: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insuli | Trial register ClinicalTrials.gov |
| 2022-02-17 | Trial | New trial registered: Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-02-08 | Results | Results posted: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-02-01 | Trial | New trial registered: Basal Plus GLP1-ra on Glycemic Variability in CKD | Trial register ClinicalTrials.gov |
| 2022-01-24 | Results | Results posted: A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes | Trial register ClinicalTrials.gov |
| 2022-01-19 | Results | Results posted: A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2022-01-12 | Trial | New trial registered: China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE) | Trial register ClinicalTrials.gov |
| 2021-12-22 | Trial | New trial registered: Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study | Trial register ClinicalTrials.gov |
| 2021-11-24 | Trial | New trial registered: Endotherapy for Painless Chronic Pancreatitis | Trial register ClinicalTrials.gov |
| 2021-11-23 | Trial | New trial registered: BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes | Trial register ClinicalTrials.gov |
| 2021-11-01 | Trial | New trial registered: Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy | Trial register ClinicalTrials.gov |
| 2021-10-06 | Trial | New trial registered: A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Dia | Trial register ClinicalTrials.gov |
| 2021-09-13 | Results | Results posted: Insulin Pump to Multiple Daily Injection Transition Clinical Trial | Trial register ClinicalTrials.gov |
| 2021-08-27 | Trial | New trial registered: Degludec Glargine U300 Hospital Study | Trial register ClinicalTrials.gov |
| 2021-07-16 | Trial | New trial registered: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM | Trial register ClinicalTrials.gov |
| 2021-07-09 | Trial | New trial registered: A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2021-07-07 | Trial | New trial registered: Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients Wit | Trial register ClinicalTrials.gov |
| 2021-06-22 | Trial | New trial registered: Afrezza® INHALE-1 Study in Pediatrics | Trial register ClinicalTrials.gov |
| 2021-05-19 | Trial | New trial registered: Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon | Trial register ClinicalTrials.gov |
| 2021-04-21 | Recall | FDA recall, Class I: Novo Nordisk Inc. Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements tha | Regulator FDA enforcement reports |
| 2021-04-21 | Recall | FDA recall, Class I: Novo Nordisk Inc. Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements tha | Regulator FDA enforcement reports |
| 2021-04-21 | Recall | FDA recall, Class I: Novo Nordisk Inc. Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements tha | Regulator FDA enforcement reports |